An SS-31 peptide cycle usually runs 4 to 12 weeks, but no standard protocol exists because SS-31 is not FDA-approved. Learn dosing, reconstitution, and risks.
An SS-31 peptide cycle is a planned schedule of repeated doses of SS-31 (elamipretide), a mitochondria-targeted tetrapeptide sold as a research chemical. Most protocols circulating online run 4 to 12 weeks of daily subcutaneous injections followed by a break of several weeks, but no cycle length or dose has been standardized or approved by the FDA. Anyone weighing a cycle should treat every published schedule as a reference point rather than a validated, safe protocol.
What SS-31 (Elamipretide) Actually Is
SS-31 is a synthetic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. It concentrates in the inner mitochondrial membrane, where it binds cardiolipin and appears to stabilize electron transport while reducing reactive oxygen species.
Stealth BioTherapeutics developed the compound, also known as elamipretide, MTP-131, and Bendavia, and ran human trials in Barth syndrome, primary mitochondrial myopathy, dry age-related macular degeneration, and heart failure. The FDA issued a complete response letter for the Barth syndrome application in 2024, meaning the agency declined to approve it.
SS-31 is not FDA-approved for human use in the United States. SS-31 is distributed as a lyophilized research powder labeled for laboratory use only, not as a prescription medication.
How a Typical SS-31 Peptide Cycle Is Structured
Because no approved protocol exists, the word cycle means different things to different people. Published trials have used fixed daily doses for 4 to 12 weeks with open-label extensions, while community protocols typically cycle on and off.
Common patterns include:
- Daily dosing for 4 to 8 weeks, then 2 to 4 weeks off.
- Five days on and two days off for 8 to 12 weeks.
- Lower daily doses for longer stretches rather than short, high-dose bursts.
The table below compares doses reported in trial literature with doses discussed in research communities. It is not a dosing recommendation.
| Source | Route | Reported dose | Reported cycle length |
|---|---|---|---|
| Barth syndrome trial (TAZPOWER) | Subcutaneous | Up to 40 mg per day | 12 weeks, then an open-label extension |
| Cardiovascular and hospital trials | IV infusion | 4 mg per day | Days to a few weeks |
| Anecdotal research-community protocols | Subcutaneous | 1 to 10 mg per day, often 2 to 4 mg | 4 to 12 weeks on, 2 to 4 weeks off |
| Anecdotal intranasal protocols | Nasal spray | 1 to 5 mg per day, split into one or two doses | 4 to 8 weeks |
The plasma half-life of elamipretide is short, roughly 2 to 4 hours in published data, which is why trials used daily or continuous administration instead of weekly dosing.
SS-31 Reconstitution and Storage Basics
Most vials arrive as a lyophilized powder, usually 10 mg or 30 mg. Technique matters, because a contaminated or degraded vial is a bigger risk than the peptide itself.
- Wipe the vial stopper and your work surface with alcohol and let both dry completely.
- Draw bacteriostatic water with a new syringe, then inject it slowly down the inside wall of the vial rather than directly onto the powder.
- Swirl gently until dissolved. Do not shake, because foaming can damage peptides.
- Add 1 to 2 mL of water to a standard 10 mg vial, which gives a concentration of 5 to 10 mg/mL.
- Refrigerate the reconstituted vial at 2 to 8 degrees Celsius, protect it from light, and discard any solution that is cloudy or contains particles.
Most ss-31 peptide reconstitution guides online are written for laboratory handling, not clinical use, and none has been validated for injection into people.
Reported Benefits and Side Effects
Reported ss-31 peptide benefits and side effects come from a small set of clinical trials plus a large volume of anecdotal reports. Trial results have been mixed: some Barth syndrome participants showed improvements in fatigue and muscle function, while larger cardiovascular trials did not meet their primary endpoints.
Benefits described in trial data or by users include:
- Reduced fatigue and better exercise tolerance in some mitochondrial disease patients.
- Lower markers of oxidative stress in laboratory and animal research.
- Subjective reports of improved recovery, sleep, and mental clarity, none of which has been confirmed in controlled studies of healthy adults.
Side effects reported in trials include:
- Injection site reactions such as pain, redness, swelling, or nodules.
- Headache, nausea, dizziness, and fatigue.
- Less common reports of low blood pressure, hives, and muscle spasms.
Injection site reactions were the most commonly reported adverse event in elamipretide clinical trials. Long-term safety data for SS-31 in healthy adults do not exist.
Anyone who experiences chest pain, fainting, or signs of a severe allergic reaction should stop use and seek medical care immediately.
Injectable, Nasal Spray, and Oral Forms Compared
Route of administration changes how much peptide reaches muscle and nerve tissue, and the evidence base is very uneven across the available forms.
| Form | Typical use | Evidence level | Key caveat |
|---|---|---|---|
| Subcutaneous injection | 1 to 10 mg daily | Most studied route in human trials | Injection site reactions; requires sterile technique |
| IV infusion | 4 mg daily in hospital trials | Studied, but clinic-only | Not practical for self-administration |
| ss-31 peptide nasal spray | 1 to 5 mg daily in split doses | Anecdotal; minimal human absorption data | Convenient, but bloodstream uptake is unproven |
| Oral capsule or liquid | Daily | Very limited | Peptides are generally broken down in the digestive tract |
Nasal and oral routes are popular because they avoid needles, but no published human pharmacokinetic study confirms that either delivers meaningful levels of SS-31 to target tissue.
Legal Status, Sourcing, and Safety Checks
SS-31 sits in the same regulatory space as most research peptides: legal to sell for laboratory study, not legal to sell as a drug, and not cleared for human consumption. Several online sellers market it directly to consumers anyway.
If you examine any ss-31 peptide buy online listing, check three things before anything else:
- A third-party certificate of analysis showing HPLC purity above 98 percent and the correct molecular mass.
- Sterility and endotoxin testing, because injectable products that fail these tests can cause serious infections.
- Clear labeling that states the actual quantity, lot number, and storage requirements.
You will also encounter supplement-style pages such as an ss-31 peptide dosage swolverine entry. Those pages typically repackage general research information for a fitness audience and should not be treated as clinical guidance.
SS-31 sold online is a research chemical, so its purity, sterility, and identity are not verified by the FDA or any other regulator. A healthcare professional can review your health history, current medications, and potential interactions before you consider a cycle.
Bottom Line on SS-31 Cycles
There is no standard SS-31 peptide cycle. Reported protocols range from short high-dose courses to long low-dose runs, and none has been validated in healthy adults.
If you decide to explore it anyway, keep expectations modest, document what you take and how you feel, and stop at the first sign of a serious reaction. The most important fact about SS-31 remains that it is not an approved drug, and no cycle can be considered risk-free.
Frequently Asked Questions
How long should an SS-31 peptide cycle last?
There is no standard cycle length. Published trials used 12 weeks of daily subcutaneous dosing in Barth syndrome, while community protocols commonly run 4 to 8 weeks followed by 2 to 4 weeks off. Because SS-31 is not FDA-approved, no cycle length has been validated for healthy adults.
What side effects has SS-31 caused in human trials?
Injection site reactions such as pain, redness, and swelling were the most frequently reported adverse event. Headache, nausea, dizziness, and fatigue also appeared in trial reports, along with rare cases of low blood pressure, hives, and muscle spasms. Long-term safety in healthy adults has not been established, so anyone with symptoms should consult a healthcare professional.
Can you legally buy SS-31 in the United States?
SS-31 is sold as a research chemical for laboratory use, not as an approved drug, and sellers usually label it as not for human consumption. Buying it for personal use sits in a regulatory gray area, and imported vials may be seized. Purity and sterility are not guaranteed by any regulator, so third-party testing documents matter.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.